ResMed Inc (RMD)

68.88
NYSE : Health Care
Prev Close 65.70
Day Low/High 68.29 / 69.38
52 Wk Low/High 48.99 / 69.38
Avg Volume 788.40K
Exchange NYSE
Shares Outstanding 140.41M
Market Cap 9.22B
EPS 2.50
P/E Ratio 26.93
Div & Yield 1.20 (1.80%)

Latest News

Trade-Ideas: ResMed (RMD) Is Today's

Trade-Ideas: ResMed (RMD) Is Today's "Roof Leaker" Stock

Trade-Ideas LLC identified ResMed (RMD) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

ResMed (RMD) Showing Signs Of Being Water-Logged And Getting Wetter

ResMed (RMD) Showing Signs Of Being Water-Logged And Getting Wetter

Trade-Ideas LLC identified ResMed (RMD) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Analysts' Actions -- Apple, JetBlue, Twitter, Xerox and More

Analysts' Actions -- Apple, JetBlue, Twitter, Xerox and More

Here are Wednesday's top research calls, including downgrades for Apple, Twitter and Xerox, and an upgrade for JetBlue.

Are ResMed Shares About to Awaken?

Shares of the maker of sleep-apnea devices are poised to rise and shine.

ResMed (RMD) Stock Gets ‘Underweight’ Rating at Barclays

ResMed (RMD) Stock Gets ‘Underweight’ Rating at Barclays

ResMed (RMD) stock coverage was reinstated with an ‘underweight’ rating and $55 price target at Barclays on Thursday morning.

Short Interest In ResMed Declines 17.7%

Short Interest In ResMed Declines 17.7%

The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 2,157,595 share decrease in total short interest for ResMed Inc. , to 10,061,207, a decrease of 17.66% since 03/01/2016.

Insider Trading Alert - SNAK, PCLN And RMD Traded By Insiders

Insider Trading Alert - SNAK, PCLN And RMD Traded By Insiders

Stocks with insider trader activity include SNAK, PCLN and RMD

RMD, XRAY And BABA, Pushing Health Services Industry Downward

RMD, XRAY And BABA, Pushing Health Services Industry Downward

TheStreet highlights 3 stocks pushing the health services industry lower today.

5 Breakout Stocks to Buy Off Weakness

5 Breakout Stocks to Buy Off Weakness

These stocks are within range of triggering big breakouts. Here's how to trade them now.

Insider Trading Alert - GENC, LPLA And RMD Traded By Insiders

Insider Trading Alert - GENC, LPLA And RMD Traded By Insiders

Stocks with insider trader activity include GENC, LPLA and RMD

Insider Trading Alert - IPWR, GLAD And RMD Traded By Insiders

Insider Trading Alert - IPWR, GLAD And RMD Traded By Insiders

Stocks with insider trader activity include IPWR, GLAD and RMD

7 Stocks to Trade for Breakouts on Big Volume

7 Stocks to Trade for Breakouts on Big Volume

These stocks trading on unusual volume are within range of triggering breakout trades.

Trade-Ideas: ResMed (RMD) Is Today's Post-Market Leader Stock

Trade-Ideas: ResMed (RMD) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified ResMed (RMD) as a post-market leader candidate

ResMed (RMD) Stock Downgraded at Barclays

ResMed (RMD) Stock Downgraded at Barclays

Barclays downgraded ResMed (RMD) and lowered its price target on the stock on Tuesday.

Analysts' Actions -- Campbell Soup, Express Scripts, Dunkin' Brands, Lennar and More

Analysts' Actions -- Campbell Soup, Express Scripts, Dunkin' Brands, Lennar and More

Here are Tuesday's top research calls, including upgrades for Campbell Soup and Lennar, and downgrades for Express Scripts and Dunkin' Brands.

FMS, RMD And BAX, Pushing Health Services Industry Downward

FMS, RMD And BAX, Pushing Health Services Industry Downward

TheStreet highlights 3 stocks pushing the health services industry lower today.

Insider Trading Alert - LPLA, RMD And FCH Traded By Insiders

Insider Trading Alert - LPLA, RMD And FCH Traded By Insiders

Stocks with insider trader activity include LPLA, RMD and FCH

CareFusion AirLife Signs New Distribution Agreement With ResMed

CareFusion AirLife Signs New Distribution Agreement With ResMed

AirLife to Offer Nasal High Flow Interfaces from ResMed

First Week of RMD November 20th Options Trading

First Week of RMD November 20th Options Trading

Investors in ResMed Inc. saw new options begin trading this week, for the November 20th expiration.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look ready to break out and trade higher from current levels.

Insider Trading Alert - ATHN, RMD And BKS Traded By Insiders

Insider Trading Alert - ATHN, RMD And BKS Traded By Insiders

Stocks with insider trader activity include ATHN, RMD and BKS

ResMed Stock Sees Short Interest Make 18.8% Move

ResMed Stock Sees Short Interest Make 18.8% Move

The most recent short interest data has been released by the NASDAQ for the 08/14/2015 settlement date, which shows a 1,846,598 share increase in total short interest for ResMed Inc. , to 11,678,916, an increase of 18.78% since 07/31/2015.

'Mad Money' Lightning Round: Forget El Pollo Loco, Buy Chipotle

'Mad Money' Lightning Round: Forget El Pollo Loco, Buy Chipotle

Cramer wants Cisco Systems over Infinera, can't understand why Cypress Semiconductor is a house of pain and is sticking with Tractor Supply.

Jim Cramer's 'Mad Money' Recap: What to Buy When the Fed Raises Rates

Jim Cramer's 'Mad Money' Recap: What to Buy When the Fed Raises Rates

If you want to make money in the markets, you need to be focused on what will be happening next, Cramer says.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

Watch Out: Barbarians At The Gate For ResMed (RMD)

Watch Out: Barbarians At The Gate For ResMed (RMD)

Trade-Ideas LLC identified ResMed (RMD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

ResMed (RMD) Stock Coverage Initiated at Barclays

ResMed (RMD) Stock Coverage Initiated at Barclays

ResMed (RMD) stock coverage was initiated at Barclays with an 'equal rating' and a price target of $61.

ResMed (RMD) Stock Falls After Sleep Apnea Treatment Misses Primary Endpoint in Phase III Trial

ResMed (RMD) Stock Falls After Sleep Apnea Treatment Misses Primary Endpoint in Phase III Trial

Shares of ResMed (RMD) plunged in late morning trading Wednesday after company provided an update on its Phase III study of SERVE-HF.